Last Updated: November 16, 2026

Details for Patent: 10,683,499

« Back to Dashboard


Summary for Patent: 10,683,499
Title:Compositions and methods for modulating TTR expression
Abstract:Provided herein are oligomeric compounds with conjugate groups. In certain embodiments, the oligomeric compounds are conjugated to N-Acetylgalactosamine.
Inventor(s):Thazha P. Prakash, Punit P. Seth, Eric E. Swayze
Assignee: Glaxo Group Ltd , Ionis Pharmaceuticals Inc
Application Number:US15/687,306
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 10,683,499

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Astrazeneca Ab WAINUA eplontersen sodium SOLUTION;SUBCUTANEOUS 217388-002 Apr 15, 2026 RX Yes Yes ⤷  Start Trial ⤷  Start Trial Y Y TREATMENT OF POLYNEUROPATHY OF HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS ⤷  Start Trial
Astrazeneca Ab WAINUA (AUTOINJECTOR) eplontersen sodium SOLUTION;SUBCUTANEOUS 217388-001 Dec 21, 2023 RX Yes Yes ⤷  Start Trial ⤷  Start Trial Y Y TREATMENT OF POLYNEUROPATHY OF HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,683,499

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 3524680 ⤷  Start Trial CA 2025 00027 Denmark ⤷  Start Trial
European Patent Office 3524680 ⤷  Start Trial C20250028 Finland ⤷  Start Trial
European Patent Office 3524680 ⤷  Start Trial 301341 Netherlands ⤷  Start Trial
European Patent Office 3524680 ⤷  Start Trial 122025000044 Germany ⤷  Start Trial
European Patent Office 3524680 ⤷  Start Trial 2025C/700 Belgium ⤷  Start Trial
European Patent Office 2991656 ⤷  Start Trial C20260001 Finland ⤷  Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.